Azurity Pharmaceuticals, Inc. et al v. Glenmark Pharmaceuticals Limited et al > Summary
Court Case Number 1:22-cv-01604
Filing Date Dec 16, 2022
Termination Date Mar 17, 2023
Court Delaware District Court
Status Dismissed - Other
JudgesMaryellen Noreika
Plaintiff Attorneys
14Azurity Pharmaceuticals, Inc.
Attorney Name: Alexandra M. Joyce
McCarter & English
Takeda Pharmaceutical Company Limited
Attorney Name: Daniel M. Silver
McCarter & English
Takeda Pharmaceutical Company Limited
Attorney Name: Alexandra M. Joyce
McCarter & English
Takeda Pharmaceutical Company Limited
Attorney Name: Daniel M. Silver
McCarter & English
Takeda Pharmaceutical Company Limited
Attorney Name: Alexandra M. Joyce
McCarter & English
Takeda Pharmaceutical Company Limited
Attorney Name: Daniel M. Silver
McCarter & English
Takeda Pharmaceutical Company Limited
Attorney Name: Alexandra M. Joyce
McCarter & English
Takeda Pharmaceutical Company Limited
Attorney Name: Zhiqiang Liu
Attorney Name: William F. Cavanaugh Jr.
Attorney Name: Michael F. Werno
Attorney Name: Chad J. Peterman
Attorney Name: Christopher P. Hill
Attorney Name: Bruce M. Wexler
Defendant Attorneys
2Related Patents
Doc No | Title | Issue date |
---|---|---|
09066936 | Solid pharmaceutical composition comprising a benzimidazole-7-carboxylate derivative and a pH control agent | Jun 30, 2015 |
07572920 | Benzimidazole derivative and use as a II receptor antagonist | Aug 11, 2009 |
07157584 | Benzimidazole derivative and use thereof | Jan 2, 2007 |